Ogawa Y - Search Results

1

Treatment of murine SCC VII tumors with localized hyperthermia and temperature-sensitive liposomes containing cisplatin.

Nishimura Y, Ono K, Hiraoka M, Masunaga S, Jo S, Shibamoto Y, Sasai K, Abe M, Iga K, Ogawa Y. Nishimura Y, et al. Among authors: ogawa y. Radiat Res. 1990 May;122(2):161-7. Radiat Res. 1990. PMID: 2336462

2

Rates of systemic degradation and reticuloendothelial system (RES) uptake of thermosensitive liposome encapsulating cisplatin in rats.

Iga K, Ogawa Y, Toguchi H. Iga K, et al. Among authors: ogawa y. Pharm Res. 1993 Sep;10(9):1332-7. doi: 10.1023/a:1018925931294. Pharm Res. 1993. PMID: 8234172

3

Heat-induced drug release rate and maximal targeting index of thermosensitive liposome in tumor-bearing mice.

Iga K, Ogawa Y, Toguchi H. Iga K, et al. Among authors: ogawa y. Pharm Res. 1992 May;9(5):658-62. doi: 10.1023/a:1015858228394. Pharm Res. 1992. PMID: 1608899

4

Increased tumor cisplatin levels in heated tumors in mice after administration of thermosensitive, large unilamellar vesicles encapsulating cisplatin.

Iga K, Hamaguchi N, Igari Y, Ogawa Y, Toguchi H, Shimamoto T. Iga K, et al. Among authors: ogawa y. J Pharm Sci. 1991 Jun;80(6):522-5. doi: 10.1002/jps.2600800604. J Pharm Sci. 1991. PMID: 1941540

5

Enhanced antitumor activity in mice after administration of thermosensitive liposome encapsulating cisplatin with hyperthermia.

Iga K, Hamaguchi N, Igari Y, Ogawa Y, Gotoh K, Ootsu K, Toguchi H, Shimamoto T. Iga K, et al. Among authors: ogawa y. J Pharmacol Exp Ther. 1991 Jun;257(3):1203-7. J Pharmacol Exp Ther. 1991. PMID: 2046024

6

Membrane modification by negatively charged stearyl-polyoxyethylene derivatives for thermosensitive liposomes: reduced liposomal aggregation and avoidance of reticuloendothelial system uptake.

Iga K, Ohkouchi K, Ogawa Y, Toguchi H. Iga K, et al. Among authors: ogawa y. J Drug Target. 1994;2(3):259-67. doi: 10.3109/10611869408996807. J Drug Target. 1994. PMID: 7812694

7

Novel sustained-release dosage forms of proteins using polyglycerol esters of fatty acids.

Yamagata Y, Iga K, Ogawa Y. Yamagata Y, et al. Among authors: ogawa y. J Control Release. 2000 Feb 3;63(3):319-29. doi: 10.1016/s0168-3659(99)00206-0. J Control Release. 2000. PMID: 10601727

8

Gastro-intestinal absorption of ethyl 2-chloro-3-[4-(2-methyl-2-phenylpropyloxy)phenyl]propionate from different dosage forms in rats and dogs.

Toguchi H, Ogawa Y, Iga K, Yashiki T, Shimamoto T. Toguchi H, et al. Among authors: ogawa y. Chem Pharm Bull (Tokyo). 1990 Oct;38(10):2792-6. doi: 10.1248/cpb.38.2792. Chem Pharm Bull (Tokyo). 1990. PMID: 2076564

9

Effects of physiological factors on the bioavailability of ethyl 2-chloro-3-[4-(2-methyl-2-phenylpropyloxy)phenyl]propionate in an emulsion in rats.

Toguchi H, Ogawa Y, Iga K, Shimamoto T. Toguchi H, et al. Among authors: ogawa y. Chem Pharm Bull (Tokyo). 1990 Oct;38(10):2801-4. doi: 10.1248/cpb.38.2801. Chem Pharm Bull (Tokyo). 1990. PMID: 2076566

10

Pharmacologic effect of recombinant human IFN-alpha, continuously released from a matrix prepared from a polyglycerol ester of fatty acids, on 2',5'-oligoadenylate synthetase activity in murine liver.

Yamagata Y, Yuasa Y, Yamamoto K, Okamoto K, Igari Y, Iga K, Ogawa Y. Yamagata Y, et al. Among authors: ogawa y. J Interferon Cytokine Res. 2000 Feb;20(2):153-60. doi: 10.1089/107999000312559. J Interferon Cytokine Res. 2000. PMID: 10714550

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,154 results

Search Page

Filters